John Hrom
Impact in
-
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Genetics 8
- Chronic Lymphocytic Leukemia Research 7
-
- Lymphoma Diagnosis and Treatment 6
- Co-authors
- Sergio Huerta (2 shared papers)Debabrata Saha (1 shared paper)Thomas Anthony (1 shared paper)Xiaohuan Gao (1 shared paper)Payal Kapur (1 shared paper)Jacob D. Bitran (2 shared papers)Mehdi M. Moezi (2 shared papers)Nizar M. Tannir (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Blood (3 papers)Hematological Oncology (1 paper)Anti-Cancer Drugs (1 paper)EClinicalMedicine (1 paper)
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
John Hrom
13 papers receiving 78 citations
Peers
Comparison fields: 5 of 23
- Oncology 47
- Genetics 17
- Hematology 17
- Pathology and Forensic Medicine 20
- Cancer Research 12
Countries citing papers authored by John Hrom
This map shows the geographic impact of John Hrom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Hrom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Hrom more than expected).
Fields of papers citing papers by John Hrom
This network shows the impact of papers produced by John Hrom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Hrom. The network helps show where John Hrom may publish in the future.
Co-authors
The 25 scholars most cited alongside John Hrom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 27 | |
| 2 | 2017 | 11 | |
| 3 | 2019 | 9 | |
| 4 | 2021 | 7 | |
| 5 | 2020 | 7 | |
| 6 | 2011 | 5 | |
| 7 | 2024 | 3 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 2 | |
| 10 | 2024 | 1 | |
| 11 | 2025 | 1 | |
| 12 | 2016 | 1 | |
| 13 | A rare case of signet ring cell gastric adenocarcinoma. | 2007 | 1 |
| 14 | 2025 | 0 | |
| 15 | 2025 | 0 |
About John Hrom
John Hrom is a scholar working on Genetics, Pathology and Forensic Medicine, Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health, having authored 15 papers that have together received 78 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (6 papers), Protein Degradation and Inhibitors (2 papers), Galectins and Cancer Biology (2 papers), Acute Lymphoblastic Leukemia research (2 papers), HER2/EGFR in Cancer Research (2 papers), CAR-T cell therapy research (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Oncology (47 citations), Genetics (17 citations), Hematology (17 citations), Pathology and Forensic Medicine (20 citations) and Cancer Research (12 citations). John Hrom has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Sergio Huerta, Debabrata Saha, Thomas Anthony, Xiaohuan Gao, Payal Kapur, Jacob D. Bitran, Mehdi M. Moezi, Nizar M. Tannir, Shahrooz Eshaghian and Ryan C. Lynch. Their work appears in journals such as Journal of Clinical Oncology, Blood, Hematological Oncology, Anti-Cancer Drugs and EClinicalMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.